PD-L1 immunohistochemical assays for assessment of therapeutic strategies involving immune checkpoint inhibitors in non-small cell lung cancer: a comparative studyHyojin Kim, Jin-Haeng Chung|Oncotarget|2017Cited by 51
The new 2023 FIGO staging system for endometrial cancer: what is different from the previous 2009 FIGO staging system?Kyung Hee Han, Hyojin Kim|Journal of Gynecologic Oncology|2024Cited by 25
Downregulation of CHIP promotes ovarian cancer metastasis by inducing Snail‐mediated epithelial–mesenchymal transitionSun‐Mi Park, Jiyun Yoo, Ki‐Jun Ryu et al.|Molecular Oncology|2019Cited by 23